Résumé
The online version contains supplementary material available at 10.1038/s41598-026-43297-y.
- Titre
- Construct validity of real-world digital mobility outcomes in patients after proximal femoral fracture: a cross-sectional observational study
- Créateurs - sans rôle
- Tobias Eckert - Heidelberg UniversityMartin Aursand Berge - Norwegian University of Science and TechnologyMichael Long - University of SheffieldMartí de las Heras - Universitat Pompeu FabraPaula Alvarez - Barcelona Institute for Global HealthHubert Blain - Centre Hospitalier Universitaire de MontpellierJulia Braun - University of ZurichJoren Buekers - Universitat Pompeu FabraBrian Caulfield - University College DublinMonika Engdal - Norwegian University of Science and TechnologyAnja Frei - University of ZurichJorunn Helbostad - Norwegian University of Science and TechnologyAnisoara Ionescu - École Polytechnique Fédérale de LausanneCarl-Philipp Jansen - Heidelberg UniversityLars Gunnar Johnsen - Norwegian University of Science and TechnologyJochen Klenk - Universität UlmSarah Koch - Universitat Pompeu FabraVita Lanfranchi - University of SheffieldLynn Rochester - NIHR Newcastle Biomedical Research CentreClemens Becker - Robert Bosch StiftungBeatrix Vereijken - Norwegian University of Science and TechnologyJudith Garcia-Aymerich - Universitat Pompeu Fabra
- Détails de publication
- Scientific Reports, Vol.16(1)
- Note de subvention
- This study is part of the Mobilise-D project, which was funded by the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 820820. This JU received support from the European Union’s Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations (EFPIA). This work was also supported by the National Institute for Health and Care Research (NIHR) Sheffield Biomedical Research Centre (NIHR203321). ISGlobal acknowledges support from the grant CEX2023-0001290-S funded by MCIN/AEI/ https://doi.org/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. MdlH was funded by European Union-NextGenerationEU, under the Program Investigo (INVESTIGO 2022, AGAUR- ref. BDNS 608313, file 2022 INV-1 00046 - Code 100046TC19). LR is supported by the IMI2 JU project IDEA-FAST (grant agreement 853981). LR is supported by the NIHR Newcastle Biomedical Research Centre based at The Newcastle upon Tyne Hospital National Health Service (NHS) Foundation Trust, Newcastle University, and the Cumbria, Northumberland, and Tyne and Wear NHS Foundation Trust and the NIHR/Wellcome Trust Clinical Research Facility infrastructure at Newcastle upon Tyne Hospitals NHS Foundation Trust. LR received funding from the NIHR Senior Investigator Awards (2020–2024 and 2024–2028). Content in this publication reflects the authors’ views and neither IMI nor the European Union, EFPIA, NHS, NIHR or the Department of Health and Social Care are responsible for any use that may be made of the information contained herein.
- Identifiants
- 99253683709311
- Unité académique
- Université de Montpellier
- Langue
- Anglais
- Type de ressource
- Article de revue scientifique
- Champs locaux
- hal-05662692